Target intelligence / Profile preview

Hydroxyapatite and Collagen Matrix (HAp/Col)

Target
HAp/Col
Molecular classification
Extracellular matrix, Biomaterial, Structural protein, Mineral
01

Overview

Hydroxyapatite and collagen matrix is the fundamental composite material of vertebrate bone, comprising an organic framework of Type I collagen fibers and an inorganic phase of calcium phosphate crystals (Wahl & Czernuszka, 2006). This matrix provides the mechanical strength and structural integrity required for the skeletal system while also serving as a reservoir for essential minerals like calcium and phosphate (Glimcher, 2006). In regenerative medicine, synthetic or processed versions of this matrix are utilized as osteoconductive scaffolds that facilitate the migration and attachment of bone-forming cells (Ferreira et al., 2020). The hydroxyapatite component is a critical pharmacological target for bisphosphonates, which bind to the mineral surface to inhibit osteoclast-mediated bone resorption in conditions like osteoporosis (Russell, 2007). Furthermore, the collagenous component provides essential motifs that interact with integrin receptors on the surface of mesenchymal stem cells to promote osteogenic differentiation (Heino, 2007). Therapeutic interventions often involve loading this matrix with growth factors, such as bone morphogenetic proteins (BMPs), to enhance its osteoinductive potential (Infante & Rodriguez, 2018). As a biomaterial, it is extensively used in orthopedic and dental surgeries to fill bone voids and promote natural healing (Wahl & Czernuszka, 2006). The degradation and remodeling of this matrix are tightly regulated by the balanced activity of osteoblasts and osteoclasts, making it a central focus for treating metabolic bone diseases (Russell, 2007).

Other names
Bone matrixMineralized collagenCollagen-hydroxyapatite scaffoldBiphasic bone graft
02

Mechanism of action

Provides a structural scaffold for osteoconduction and serves as a high-affinity binding site for bone-seeking minerals and drugs.

03

Biological functions

Structural supportMineral homeostasisOsteoconductionCell adhesion
04

Disease associations

Bone fractureOsteoporosisBone defectPeriodontal disease
05

Safety considerations

ImmunogenicityEctopic ossificationInfection riskDegradation rate mismatch
06

Interacting drugs

Alendronate

5 more in the full profile.

07

Biomarkers

Alkaline phosphataseOsteocalcinProcollagen type I N-terminal propeptide

Beyond the preview

Go deeper on Hydroxyapatite and Collagen Matrix (HAp/Col).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hydroxyapatite and Collagen Matrix (HAp/Col).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call